Corrole chemistry has witnessed an impressive boost in studies in the last 20 years, thanks
to the possibility of preparing corrole derivatives by simple synthetic procedures. The …

Colorectal cancer (CRC) is the third most common diagnosed malignancy among both
sexes in the United States as well as in the European Union. While the incidence and …

Recently, a strong correlation between metabolic disorders, tumor onset, and progression
has been demonstrated, directing new therapeutic strategies on metabolic targets. OLR1 …

Cardiovascular diseases (CVDs), specifically lipid-driven atherosclerotic CVDs, remain the
number one cause of death worldwide. The lectin-like oxidized low-density lipoprotein (LDL) …

Peritoneal metastasis (PM) occurs in approximately one in four colorectal cancer (CRC)
patients. The pathophysiology of colorectal PM remains poorly characterized. Also, the …

Lipid metabolism disorder is related to an increased risk of tumorigenesis and is involved in
the rapid growth of cancer cells as well as the formation of metastatic lesions …

High-throughput phenotyping is becoming increasingly available thanks to analytical and
bioinformatics approaches that enable the use of very high-dimensional data and to the …

As a subset of pattern recognition receptors (PRRs), C-type lectin-like receptors (CLRs) are
mainly expressed by myeloid cells as both transmembrane and soluble forms. CLRs …

Chemoresistance is one of the major problems of colon cancer treatment. In tumors,
glycolytic metabolism has been identified to promote cell proliferation and chemoresistance …

Epidemiological relationships between cancer and cardiovascular diseases have been
reported, but a molecular basis remains unclear. Some proteoglycans that strongly bind low …